Screener
Oric Pharmaceuticals, Inc. ORIC Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by Oric Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The source filing: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-204047
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Operating expenses: | ||
| Research and development | $31,437 | $24,640 |
| General and administrative | 8,182 | 8,078 |
| Total operating expenses | 39,619 | 32,718 |
| Loss from operations | (39,619) | (32,718) |
| Other income, net | 3,852 | 2,697 |
| Net loss | $(35,767) | $(30,021) |
| Other comprehensive loss: |
Item 1. Financial Statements.
FAQ
- What is Oric Pharmaceuticals, Inc.'s total operating expenses?
- Oric Pharmaceuticals, Inc. (ORIC) reported total operating expenses of $39.62M in Q1 2026.
- How has Oric Pharmaceuticals, Inc.'s total operating expenses changed year-over-year?
- Oric Pharmaceuticals, Inc.'s total operating expenses increased by 21.1% year-over-year, from $32.72M to $39.62M.
- What is the long-term trend for Oric Pharmaceuticals, Inc.'s total operating expenses?
- Over 4 years (2021 to 2025), Oric Pharmaceuticals, Inc.'s total operating expenses has grown at a 16.0% compound annual growth rate (CAGR), from $78.87M to $143M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.
Ask your AI about Oric Pharmaceuticals, Inc.'s total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude